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ADP-ribosyltransferases (ARTD1–16) have emerged
as major downstream effectors of NAD+ signaling in
the cell. Most ARTDs (ARTD7 and 8, 10–12, and 14–
17) catalyze the transfer of a single unit of ADP-ribose
from NAD+ to target proteins, a process known as
mono-ADP-ribosylation (MARylation). Progress in
understanding the cellular functions of MARylation
has been limited by the inability to identify the direct
targets for individual mono-ARTDs. Here, we engi-
neered mono-ARTDs to use an NAD+ analog that is
orthogonal to wild-type ARTDs. We profiled the
MARylomes of ARTD10 and ARTD11 in vitro, identi-
fying isoform-specific targets and revealing a poten-
tial role for ARTD11 in nuclear pore complex biology.
We found that ARTD11 targeting is dependent on
both its regulatory and catalytic domains, which
has important implications for how ARTDs recognize
their targets. We anticipate that our chemical genetic
strategy will be generalizable to all mono-ARTD fam-
ily members based on the similarity of the mono-
ARTD catalytic domains.
INTRODUCTION
ADP-ribosylation—the transfer of the ADP-ribose (ADPr) moiety
from nicotinamide adenine dinucleotide (NAD+) to amino acids in
proteins—is a reversible posttranslational modification essential
for cellular function in mammals (Hottiger et al., 2010). The en-
zymes that catalyze ADP-ribosylation, known as ADP-ribosyl-
transferases (ARTDs, 15 active family members in humans) or
poly-ADP-ribose polymerases (PARPs), have been implicated
in a number of physiological roles, including gene regulation
(Zhang et al., 2012), differentiation (Hu et al., 2013), and signal
transduction (Strosznajder et al., 2005), as well as a number of
diseases—notably neurodegeneration (Cosi and Marien, 1999)
and cancer (Masutani and Fujimori, 2013). As such, the cellular
functions of each ARTD family member and their downstream
targets have generated significant biological interest; however,Cthe targets of most ARTDs are unknown, which has hampered
efforts to delineate their specific roles in cellular processes.
While ARTDs were termed polymerases based on their ho-
mology to the catalytic domain of the founding member
ARTD1 (a verified polymerase), most ARTD family members
(ARTDs 7–8, 10–12, and 14–17) catalyze mono-ADP-ribosylation
(MARylation) and not poly-ADP-ribosylation (PARylation) as pre-
viously thought (Vyas et al., 2014). The ARTDs that catalyze
MARylation, referred to here as mono-ARTDs, are not under-
stood in nearly as much detail as the ARTDs that catalyze
PARylation, referred to here as poly-ARTDs. This is due, in
part, to the lack of chemical tools to study MARylation in the
cell. PARylated and MARylated proteins can be enriched using
different protein domains (e.g., macro) (Jungmichel et al., 2013)
or the modification of the ADPr adduct with chemical tags
(e.g., biotin, boronate resin) (Jiang et al., 2010; Zhang et al.,
2013) followed by protein identification by liquid chromatog-
raphy and tandem mass spectrometry (LC-MS/MS). But, none
of these methods are able to distinguish between MARylation
and PARylation, and, most importantly, they cannot determine
which mono-ARTD is responsible for a given modification. This
means that advances in mono-ARTD biology have been pains-
taking, requiring the identification of targets through traditional
molecular biology approaches. Complicating matters further,
the mono-ARTD family members are known to form complexes
with each other in the cell and could be playing semi-redundant
roles in signal transduction (Leung et al., 2011). To push this field
forward, new strategies are needed to link a given mono-ARTD
to its direct protein targets.
Herein, we report a chemical genetic (‘‘bump-hole’’) strategy
to label the specific targets of a single engineered mono-ARTD
with a clickable NAD+ analog containing a benzyl substituent
at the C-5 position of the nicotinamide ring and an alkyne tag
at the N-6 position of the adenosine ring (5-Bn-6-a-NAD+). In
this strategy, the benzyl substituent acts as a ‘‘bump,’’ prevent-
ing 5-Bn-6-a-NAD+ from being used as a substrate for wild-type
ARTDs. The engineered mono-ARTD contains a unique pocket,
or ‘‘hole,’’ that can accommodate the benzyl substituent and effi-
ciently use 5-Bn-6-a-NAD+ as a substrate. Thus, 6-a-ADPr from
5-Bn-6-a-NAD+ will only be incorporated by an engineered
mono-ARTD, facilitating orthogonal—and mono-ARTD-spe-
cific—target identification. When combined with LC-MS/MSell Reports 14, 621–631, January 26, 2016 ª2016 The Authors 621
analysis, we successfully identified a set of 140 preferred
ARTD10-specific targets that are involved in a wide array of bio-
logical processes. We also identified a set of 21 preferred
ARTD11-specific targets that are primarily involved in nuclear
pore complex biology (Natalizio and Wente, 2013). This identifi-
cation of cellular ARTD11 targets implicates ARTD11 in a previ-
ously uncharacterized biological role. Finally, we implemented
our strategy to explore the requirements for target recognition
at both the NAD+ active site and the modular N-terminal regula-
tory domains of ARTDs 10 and 11. We provide evidence that the
structurally conserved ARTDcat domains and the non-conserved
modular N-terminal regulatory domains in the mono-ARTD
family play specific, and necessary, roles in precise target
recognition.
RESULTS
Identification of EngineeredMono-ARTD-ModifiedNAD+
Analog Pairs
We recently adapted a sensitized enzyme-modified substrate
(‘‘bump-hole’’) method for identifying the direct protein targets
of poly-ARTDs (Carter-O’Connell and Cohen, 2015; Carter-
O’Connell et al., 2014). This method involved mutating an active
site lysine residue (Lys903 in human ARTD1, referred to here as
the ‘‘ceiling’’ position) to an alanine to create a unique pocket for
accommodating aC-5 ethyl group on the nicotinamide ring of the
NAD+ analog, 5-Et-6-a-NAD+. This NAD+ analog contains an
alkyne at the N-6 position of the adenine ring to aid in target iden-
tification using click conjugation to a rhodamine-azide or biotin-
azide. We showed that 5-Et-6-a-NAD+ was used as a selective
substrate for K903A (KA-), but not wild-type (WT-) ARTD1, and
mutation of the ceiling lysine to an alanine in the other poly-
ARTDs gave similar results (Carter-O’Connell and Cohen,
2015; Carter-O’Connell et al., 2014).
Unlike the poly-ARTDs, the mono-ARTDs do not have a lysine
at the ceiling position; rather, they contain a leucine (ARTD10,
15), an isoleucine (ARTD16, 17), or a tyrosine (ARTD7, 8, 11,
12, and 14) as demonstrated by a structure-based sequence
alignment (Figure 1A). Overlay of the crystal structures of 3-ami-
nobenzamide-bound ARTD10 (PDB ID: 3HKV) and ARTD1 (Ruf
et al., 1998) reveals that Leu926 in ARTD10 occupies a similar
space as Lys903 in ARTD1 (Figure 1B), suggesting that mutation
of the ceiling position in mono-ARTDs to a smaller amino acid
(e.g., alanine or glycine) would accommodate 6-a-NAD+ analogs
containing a substitution at the C-5 position of the nicotinamide
ring.
We first sought to determine if mutation of Leu926 to an
alanine or glycine in ARTD10 would confer sensitivity to C-5
substituted 6-a-NAD+ analogs. In addition to our original 6-a-
NAD+ analog, 5-Et-6-a-NAD+, we synthesized a panel of analogs
containing either a methyl, propyl, iso-butyl, or benzyl group at
the C-5 position (5-Me-6-a-NAD+, 5-Pr-6-a-NAD+, 5-iBu-6-a-
NAD+, and 5-Bn-6-a-NAD+, respectively) to further probe the
unique binding pockets in engineered mono-ARTDs (Scheme
S1). To test engineered ARTD10-C-5 substituted 6-a-NAD+
analog pairs, we monitored ARTD10 catalytic domain
(ARTD10cat)-mediated MARylation of the known substrate
SRSF protein kinase 2 (SRPK2) (Haikarainen et al., 2013; Morgan622 Cell Reports 14, 621–631, January 26, 2016 ª2016 The Authorsand Cohen, 2015) by click conjugation to a rhodamine-
azide probe and subsequent in-gel fluorescence detection (Fig-
ure 1C). 6-a-NAD+ was used as a substrate to mediate SRPK2
MARylation by WT-ARTD10cat, and to a lesser extent by
L926A- and L296G-ARTD10cat (Figures 1D and 1E). Importantly,
none of the C-5 substituted 6-a-NAD+ analogs were used byWT-
ARTD10cat (Figures 1D and 1E). 5-Me-6-a-NAD
+ and 5-Et-6-a-
NAD+ were used by L296G-ARTD10cat but were very poor sub-
strates (5% MARylation activity compared to WT-ARTD10cat
with 6-a-NAD+, Figures 1D and 1E). On the basis of these results,
we sought an alternative position within the nicotinamide binding
site of mono-ARTDs that, whenmutated to a smaller amino acid,
might confer sensitivity to our orthogonal NAD+ analogs.
We hypothesized that Ile987 (human ARTD10 numbering) in
the ‘‘floor’’ position of ARTD10 was a good candidate for our
enzyme-engineering approach for two reasons: (1) it makes
van der Waals contacts with the C-5 position of the benzamidine
ring of 3-aminobenzamide (Figure 1B); and (2) it is well-
conserved across the mono-ARTD subfamily (Figure 1A). We
therefore mutated Ile987 in ARTD10cat to either an alanine or
glycine and determined if these engineered ARTD10cat mutants
could use C-5 substituted 6-a-NAD+ analogs as substrates.
We found that 5-Bn-6-a-NAD+ was used efficiently by I987G-
ARTD10cat (140% MARylation activity compared to WT-
ARTD10cat with 6-a-NAD
+, Figures 1D and 1E); by contrast,
6-a-NAD+ was a poor substrate for I987G-ARTD10cat (5%
MARylation activity compared to WT-ARTD10cat with
6-a-NAD+, Figures 1D and 1E). The apparent KM (KM(app)) for
5-Bn-6-a-NAD+ for IG-ARTD10cat was similar to the KM(app) for
6-a-NAD+ for WT-ARTD10cat (KM(app) = 79.7 versus 69.6 mM,
respectively, Figure S1A). Taken together, these results demon-
strate that mutation of Ile987 in the floor position of ARTD10
results in an orthogonal switch in substrate specificity from
6-a-NAD+ to 5-Bn-6-a-NAD+.
We next sought to determine whether mutating the floor posi-
tion in another mono-ARTDwould confer sensitivity to 5-Bn-6-a-
NAD+. We expressed WT-ARTD7cat and L659G-ARTD7cat and
tested their in vitro MARylation activity with both 6-a-NAD+ and
5-Bn-6-a-NAD+. Similar to I987G-ARTD10cat, L659G-ARTD7cat
used 5-Bn-6-a-NAD+ selectively toMARylate SRPK2 (Figure S2).
Importantly, WT-ARTD7cat did not use 5-Bn-6-a-NAD
+ (Fig-
ure S2). As all of the mono-ARTDs contain either a leucine or
isoleucine at the I987 position (with the exception of ARTD16),
this result suggests that either residue can be mutated to glycine
to generate a 5-Bn-6-a-NAD+-sensitive allele throughout the
mono-ARTD subclass.
The IG-ARTD10-5-Bn-6-a-NAD+ Pair Specifically Labels
Direct Protein Targets in Multiple Cell Lines
We next determined if I987G-ARTD10 could be used to label
direct protein targets in a cellular context. GFP-I987G-ARTD10
(IG-ARTD10) or GFP-WT-ARTD10 (WT-ARTD10) were ex-
pressed in human embryonic kidney (HEK) 293T cells, and
lysates were prepared and incubated with increasing concentra-
tions of 5-Bn-6-a-NAD+ (1–100 mM), followed by click con-
jugation with biotin-azide. Only at 100 mM5-Bn-6-a-NAD+, which
is near the KM(app) for 5-Bn-6-a-NAD
+ for IG-ARTD10 (Fig-
ure S1A), did we reliably detect the labeling of several bands
Figure 1. Identification of Engineered Mono-ARTD-Modified NAD+ Analog Pairs
(A) Sequence alignment of the nicotinamide binding site of the poly-ARTDs (above dashed line) and the mono-ARTDs (below). Numbering reflects the amino acid
position in ARTD1.
(B) Overlay of the crystal structures of ARTD1cat (dark green) (PDB ID: 3PAX, Ruf et al., 1998) and ARTD10cat (yellow) (PDB ID: 3HKV) showing the nicotinamide
binding sites. The distance between the key amino acids identified in ARTD10, L926 and I987, and the C-5 position of 3-methoxybenzamide are indicated.
(C) ARTD10 variants were incubated with the ARTD10 target, SRPK2, in the presence of each individual NAD+ analog. Modified SRPK2 was subjected to ‘‘click’’
conjugation with a fluorogenic probe, and total MARylation was observed using in-gel detection.
(D) Results from orthogonal SRPK2 MARylation screen. Engineered ARTD10 variants are listed above the gels. C-5 substitutions on the nicotinamide ring are
indicated. For each modified NAD+ analog tested, the same gel was first fluorescently imaged to detect SRPK2 MARylation (top gel, gray) and then stained to
detect total SRPK2 (bottom gel, blue).
(E) A heatmap depicting the global MARylation efficiency normalized against the total loaded protein for the engineered pairs tested in (D).
See also Figure S1.
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Figure 2. IG-ARTD10 Orthogonally Labels
Protein Targets in the Presence of 5-Bn-6-
a-NAD+
(A) Lysate labeling by WT-ARTD10 and IG-
ARTD10 in the presence of 5-Bn-6-a-NAD+.
HEK293T cells were transfected with either WT-
ARTD10 or IG-ARTD10 and the resulting lysate
was incubated for 2 hr in the presence of varying
amounts of 5-Bn-6-a-NAD+. MARylation of direct
protein targets was observed using streptavidin-
HRP (Biotin). The faint bands in the WT-ARTD10
lane correspond to endogenous biotinylated pro-
teins. Expression of ARTD10 was confirmed via
immunoblot detection of GFP. Shown is a repre-
sentative image from duplicate measurements.
(B) Venn diagram comparing the IG-ARTD10 tar-
gets identified via single LC-MS/MS runs in either
HEK293T or HeLa cells.
(C) Observed distribution functions for the IG-
ARTD10 targets identified via single LC-MS/MS
runs in either HEK293T (top) or HeLa (bottom)
cells. The distributions for the total protein pool (total) as well as the subset of proteins that were identified in both HEK293T and HeLa (shared) are indicated. The
shared targets identified in HEK293T cells display significantly elevated peptide counts per identified protein as compared to the total target pool (p < 0.05, non-
parametric Mann-Whitney U test). The shared targets identified in HeLa cells also display elevated peptide counts per protein, but the difference compared to the
total target pool is not significant.
(D) Immunoblot detection of the LC-MS/MS identified ARTD10 targets (GFP-ARTD10, XPO5, WRIP1) following NeutrAvidin enrichment. MARylation levels were
determined using streptavidin-HRP (Biotin). Differences in labeling efficiency between HEK293T and HeLa lysate required separate immunoblot exposures.
See also Figure S3 and Tables S1 and S2.(especially lower molecular weight products) with the predo-
minant band corresponding to the size of auto-MARylated IG-
ARTD10 (Figure 2A). By contrast, treatment of lysates from
WT-ARTD10-transfected cells or non-transfected cells with
100 mM 5-Bn-6-a-NAD+ resulted in a low-level of background la-
beling—most likely due to endogenously biotinylated proteins
(Figure 2A). These results demonstrate that the IG-ARTD10-5-
Bn-6-a-NAD+ pair can be used to label direct MARylation targets
of ARTD10.
We next sought to use our labeling method to identify the
direct MARylation targets of ARTD10 using LC-MS/MS.
HEK293T lysates generated from cells expressing WT-ARTD10
or IG-ARTD10 were treated with 5-Bn-6-a-NAD+ (100 mM).
MARylated proteins were conjugated to biotin-azide, enriched
using NeutrAvidin agarose, digested with trypsin, and subjected
to LC-MS/MS (Figure S3A). We identified 803 ARTD10-specific
protein targets (Table S1, thresholds discussed in Experimental
Procedures). This represents amuch broader target set than that
found for either ARTD1 or ARTD2 (42 and 301 proteins, respec-
tively), which we found surprising (Carter-O’Connell et al., 2014).
We also find no overlap with the ARTD10 targets identified by us-
ing protein microarrays (Feijs et al., 2013). This could be due to
differences in the context in which the labeling reactions are per-
formed. Nonetheless, we have identified a set of ARTD10 targets
in a complex cellular context. As all other PAR and MAR detec-
tion methods rely on non-family-member-specific labeling
methods, these findings provide an identification of ARTD10-
specific targets in a cellular context.
Given the scarcity of data regarding the physiological role of
ARTD10, including its basal activity in different cell types, we
thought that perhaps the choice of cell type could be inflating
the actual target list of ARTD10 targets. To address this possi-624 Cell Reports 14, 621–631, January 26, 2016 ª2016 The Authorsbility, we repeated the labeling experiment in HeLa cells (Fig-
ure S3A). In HeLa cells, we identified 256 direct ARTD10 targets
(Table S2). The overall lower number of direct targets identified in
HeLa versus HEK293T cells likely reflects the lower expression
of GFP-ARTD10 in HeLa compared to HEK293T cells. Nonethe-
less, a comparison with the list of ARTD10 targets identified in
HEK293T cells revealed that a majority of the targets found in
HeLa cells (69%) were also identified in the HEK293T samples
(Figure 2B).
To identify the most relevant cellular targets of ARTD10, we
ranked each of the ARTD10 direct protein targets based on the
number of peptide counts per protein identified in the LC-MS/
MS analysis. We reasoned that preferred ARTD10 targets would
be labeled more efficiently and would thus be enriched to a
higher degree. Based on this enrichment, preferred ARTD10
target peptide fragments would also appear more frequently in
the LC-MS/MS run. Importantly, the control sample generated
from lysates expressing WT-ARTD10 allowed us to remove any
proteins that would be enriched for non-enzymatic reasons
from this analysis. The bulk of IG-ARTD10 targets identified in
HEK293T cells were identified based on a median of two pep-
tides. Selecting for proteins that were also identified in HeLa cells
causes a shift in median peptide counts from two to six peptides
per protein. The cumulative distribution frequency of peptide
counts per identified protein target for the shared protein pool
(HEK293T and HeLa targets) is elevated significantly above the
cumulative distribution generated from the total pool of
HEK293T protein targets (p < 0.0001, Mann-Whitney test, Fig-
ure 2C). As the majority of HeLa targets are shared with
HEK293T, there was not a significant difference in the cumulative
distribution frequencies between the shared and total HeLa
target pools (Figure 2C). While we acknowledge that some of
Figure 3. IG-ARTD10 and IG-ARTD11
MARylate Separate and Family-Member-
Specific Protein Targets
(A) Lysate labeling by IG-ARTD10 or IG-ARTD11 in
the presence of 5-Bn-6-a-NAD+. HEK293T cells
were transfected with either WT- or IG-ARTD10
or -ARTD11, and the resulting lysate was incu-
bated for 2 hr in the presence of 5-Bn-6-a-NAD+.
MARylation of direct protein targets was observed
using streptavidin-HRP (Biotin). The faint bands in
the WT-ARTD lanes correspond to endogenous
biotinylated proteins. Expression of each ARTD
was confirmed via immunoblot detection of GFP.
Shown is a representative image from duplicate
experiments.
(B) Venn diagram comparing the total IG-ARTD10
target pool with both the current IG-ARTD11 and
the previously identified KA-ARTD1 and KA-
ARTD2 (Carter-O’Connell et al., 2014) target
pools. The protein counts in bold represent the
protein targets identified in both LC-MS/MS IG-
ARTD10 replicates, while the counts in parenthe-
ses represent targets identified in at least one
replicate. IG-ARTD10-specific targets are shown
in the gray circle.
(C) IG-ARTD11 LC-MS/MS targets treated as
in (B).
(D) Circle plots depicting enriched GO terms
attached to the IG-ARTD10- (left, cyan) or IG-
ARTD11- (right, yellow) specific LC-MS/MS
identified targets in either replicate. GO term
enrichment was performed using the PANTHER
toolkit. Significantly enriched GO terms (p < 0.05)
were condensed using Revigo, and similar terms were plotted based on semantic similarity. Select groups of terms are indicated. Circle radii are scaled
proportionally to the –log10(p value). The IG-ARTD11-specific proteins associated with RNA transport are listed.
See also Figure S3 and Tables S1, S3, and S4.the targets identified with lower peptide counts in the LC-MS/MS
analysis might still represent relevant cellular targets of ARTD10,
the ranking of proteins based on peptide frequency counts—as
well as their likelihood to be found in multiple cell lines—provides
a starting point for linking ARTD10-specific MARylation to
cellular processes.
To confirm our LC-MS/MS results, we selected the shared
HeLa and HEK293T targets XPO5 and WRIP1 for identification
by western blot with target-specific antibodies after NeutrAvidin
enrichment. We found that XPO5 and WRIP1, as well as auto-
MARylated IG-ARTD10, were selectively enriched from lysates
generated from either HEK293T or HeLa cells expressing IG-
ARTD10 and treated with the 5-Bn-6-a-NAD+ (Figure 2D; Fig-
ure S3B). Taken together, our results demonstrate that our
method can be used for the identification of direct MARylation
targets of ARTD10 in a complex mixture.
ARTD11 and ARTD10 MARylate Separate Target Pools
Involved in Distinct Cellular Processes
We next wanted to demonstrate the generalizability of our
method by identifying the direct MARylation targets of another
mono-ARTD. We were particularly interested in exploring the
target profile of ARTD11 for a number of reasons: (1) ARTD11
is composed of a fairly simple modular structure as compared
to the other mono-ARTDs—with only a WWE domain attachedCto the catalytic ARTD domain—which would allow us to explore
how non-catalytic domains dictate target selection; (2) ARTD11
has an isoleucine (Ile313, ARTD11 numbering) at the ARTD10-
I987 position, but a tyrosine at the ARTD10-L926 position, allow-
ing us to confirm that our method will work with mono-ARTDs
with different amino acids at the L926-I987 interface; (3) the com-
parison of two separate mono-ARTD target profiles would allow
us to examine the level of redundant target selection in the
mono-ARTD family; and (4) recent work has implicated
ARTD11 in nuclear membrane maintenance (Meyer-Ficca
et al., 2015) providing us with a potential biological pathway to
probe our target list against.
We first compared the MARylation activity of GFP-I313G-
ARTD11 (IG-ARTD11) to IG-ARTD10 in HEK293T lysates. As
with WT-ARTD10, the KM(app) of WT-ARTD11 for 6-a-NAD
+ was
80 mM (Figure S1B), so we kept the 5-Bn-6-a-NAD+ concentra-
tion in lysates at 100 mM. Treatment of lysates from IG-ARTD11-
transfected cells with 5-Bn-6-a-NAD+ resulted in labeling of
several bands (Figure 3A). Minimal background labeling was de-
tected in lysates expressing WT-ARTD11, further demonstrating
the inability of non-engineered mono-ARTDs to use 5-Bn-6-a-
NAD+ as a substrate for MARylation. The banding pattern for
IG-ARTD11 is different from that produced by ARTD10, indi-
cating that ARTD11 and ARTD10 are indeed targeting distinct
and family-member-specific proteins (Figure 3A).ell Reports 14, 621–631, January 26, 2016 ª2016 The Authors 625
Table 1. Direct Protein Targets Identified by LC-MS/MS
KA-
ARTD1a
KA-
ARTD2a
IG-
ARTD 10
IG-
ARTD 11
Total proteins
identified
123 488 961 479
Proteins with two or
more unique peptides
91 428 848 294
Proteins enriched above
backgroundb
38 279 803 260
Proteins identified in
duplicate
16 NDc 140 21
ARTD family-member-
specific proteinsd
13/14 117/NDc 537/94 43/13
See also Tables S1 and S3.
aKA-ARTD1 and KA-ARTD2 targets were identified as previously
described (Carter-O’Connell et al., 2014).
bDefined asR2-fold enrichment in the IG-ARTD sample versus the WT-
ARTD sample.
cKA-ARTD2 identification was completed for a single replicate and is not
included in the duplicate analysis.
dTargets that were identified for a single ARTD family member from the
collected datasets from either at least a single replicate (left) or in dupli-
cate (right).Next, we sought to identify the direct targets of ARTD11 using
LC-MS/MS. HEK293T lysates generated from cells expressing
WT-ARTD11 or IG-ARTD11 were treated with 5-Bn-6-a-NAD+
(100 mM). MARylated proteins were conjugated to biotin-azide,
enriched using NeutrAvidin agarose, digested with trypsin, and
subjected to LC-MS/MS (Figure S3A). We identified a total of
260 direct IG-ARTD11 targets (thresholds discussed in Experi-
mental Procedures). Of the 803 and 260 protein targets identified
for ARTD10 and ARTD11, respectively, in this study, we identi-
fied 140 and 21 proteins in duplicate biological replicates (Ta-
ble 1). For the subsequent analysis comparing ARTD10 and
ARTD11 MARylation, we focused on targets that were present
in both replicates. We reasoned that the identification of the
same target in multiple independent replicates would increase
our confidence that a given protein was a real ARTD target. It
is possible that proteins identified in a single replicate still repre-
sent cellular ARTD10/ARTD11 targets, so we have compiled full
datasets for the combined protein pools (Tables S1 and S3).
Based on our previous observations with KA-ARTD1 and KA-
ARTD2, as well as the current study, it is apparent that the
ARTD family displays a spectrum of target specificity. In the
case of both ARTD2 and ARTD10, we observe a broad range
of cellular targets, while ARTD1 and ARTD11 have a much nar-
rower target profile (Table 1). Taken together, our strategy has
yielded a dataset capable of distinguishing the PAR and MAR
targeting preferences for multiple ARTD family members.
Our LC-MS/MS analysis allowed us to address a critical
outstanding question in the ARTD field: How much redundancy
in target selectivity exists between different ARTD family mem-
bers? Comparing our collected protein target lists for KA-
ARTD1, KA-ARTD2, IG-ARTD10, and IG-ARTD11 we have
been able to identify the extent of overlap between these
ARTD familymembers. Interestingly, the ARTD10 target list over-626 Cell Reports 14, 621–631, January 26, 2016 ª2016 The Authorslaps to a greater degree with each of the ARTD family members
than ARTD11 (Figures 3B and 3C). ARTD10 and ARTD2, in
particular, share 40 (29%of the total ARTD10 target pool) protein
targets (Figure 3B), while ARTD11 only shares two targets with
ARTD2 and no targets with ARTD1 (Figure 3C). Comparing the
combined target pools also allows us to isolate the protein tar-
gets that are specific for a given ARTD family member. The
bulk of the identified protein targets are actually unique to either
ARTD10 (67%) or ARTD11 (62%).
Using the target datasets for each of the ARTDs detailed
above, we next wanted to identify potential cellular roles for
ARTD10- and ARTD11-mediated MARylation. Using the set of
ARTD10- and ARTD11-specific target proteins, we searched
for gene ontology (GO) terms that were significantly enriched
(p < 0.05, Bonferroni correction) within either the ARTD10 or
ARTD11 target list (Table S4). The GO term enrichment profile
for ARTD10 displayed a wide spectrum of biological processes,
with enriched terms such as cellular metabolism (p = 1.73e-12),
intracellular protein transport (p = 2.26e-10), protein targeting to
the ER (p = 1.75e-07), andmRNAmetabolism (p = 6.68e-05) (Fig-
ure 3D; Table S4). Interestingly, a number of the ARTD10 targets
are involved in ubiquitin transfer and mRNA regulation. Given
that ARTD10 contains ubiquitin-interaction motifs (UIMs) and
RNA recognition motifs (RRMs), these GO results seem to align
with the proposed functions of ARTD10. For ARTD11, we
noticed that the proteins identified in duplicate were primarily nu-
clear pore proteins or proteins involved in nuclear membrane or-
ganization (13 of 21 proteins). The enrichment of nuclear pore
proteins led to enrichment of processes related to nuclear enve-
lope organization (p = 7.27e-24) and RNA transport (p = 2.62e-
24) (Figure 3D; Table S4). Taken together, the GO term profiles
for each of the ARTD enzymes are distinct, with the ARTD11 pro-
file implicating a specific and novel biological role for ARTD11
MARylation in nuclear pore complex regulation.
Although our method relies on the identification of direct tar-
gets of mono-ARTDs in cell lysates, we find that the majority of
the protein targets for both ARTD10 and ARTD11 are found in
similar cellular compartments as our GFP-ARTD constructs.
ARTD10 is localized primarily to the cytoplasm (Figure S4),
though it is thought to be able to traffic to the nucleus under the
correct stimulus paradigm (Kleine et al., 2012). We find that our
IG-ARTD10 construct indeedmodifies both cytoplasmic and nu-
clear targets. GFP-ARTD11 is enriched at the nuclear membrane
(Figure S4), and themajority of ARTD11 targets are nuclear pore-
associated proteins. GFP-ARTD11 is also found in lower levels in
the cytoplasm, accounting for the few cytoplasmic proteins we
identified. Taken together, our results suggest that the IG-
ARTD targets maintain correct targeting in cell lysates.
Both the Mono-ARTDcat and the Modular N-Terminal
Domains Are Necessary for Accurate ARTD11-Mediated
MARylation
The ARTD family is defined by the presence of a conserved
ARTDcat domain (Ame et al., 2004). Each of the mono-ARTDs
is then differentiated by the presence of at least one separate
modular domain (i.e., WWE, Zn fingers, macro, etc.) found on
the N terminus of the mono-ARTD protein (Schreiber et al.,
2006). A major unanswered question in the ARTD field is whether
Figure 4. ARTD11cat and ARTD11 WWE Domains Are Necessary but
Insufficient to Drive ARTD11-Specific MARylation
(A) Domain architecture of ARTD11, ARTD10, and the chimeric protein
(Chimera) created by fusing the ARTD11 N terminus to the ARTD10cat domain.
(B) Pie chart representing the total MARylated protein targets identified via LC-
MS/MS for the chimeric protein. Shared protein targets are indicated by the
protein schematics depicted in (A). Shared protein targets were identified
based on their presence in at least one of the IG-ARTD10 or IG-ARTD11 LC-
MS/MS replicates.
(C) Immunoblot detection of select LC-MS/MS identified ARTD targets (GFP-
ARTD, UBE3C, XPO5, NXF1, NUP98, NAGK, WRIP1) following NeutrAvidin
enrichment. Overall MARylation levels were determined using streptavidin-
HRP (Biotin). ARTD10-specific, ARTD11-specific, ARTD11-WWE dependent,
and shared chimera targets are indicated to the left.
See also Figure S3 and Tables S1, S3, and S5.the N-terminal regulatory domain alone, the ARTDcat domain
alone, or both together mediate substrate targeting. One of the
unique advantages of our engineered mono-ARTD-modified
NAD+ analog pairs is the ability to decouple proximal (i.e.,
ARTDcat) and distal (i.e., N-terminal domain) elements ofCmono-ARTD protein targeting and address this question on a
proteome-wide scale.
The ARTDcat domain from ARTD10 is attached to an RRM, a
nuclear export sequence, and a set of UIMs, whereas the
ARTD11cat domain is attached only to a WWE domain
(Figure 4A). To address the differential protein target selection
requirements for each of these domains, we fused the IG-
ARTD10cat domain to theWWEdomain fromARTD11 (Figure 4A).
The resulting chimeric protein nowpossesses the distal targeting
features of ARTD11 and the proximal targeting features of
ARTD10. Interestingly, the chimeric protein is no longer actively
exported from the nucleus (like ARTD10) nor localized selectively
to the nuclear membrane (like ARTD11) (Figure S4), allowing ac-
cess to the full range of protein targets in the cell. By comparing
the direct protein targets of the IG-chimera with the targets of IG-
ARTD10 and IG-ARTD11, we can identify which targets are
selected based on proximal and/or distal interactions.
We next performed LC-MS/MS analysis on HEK293T lysate
from cells expressing IG-chimera that were treated with the
5-Bn-6-a-NAD+ (Figure S3A). We identified a total of 85 IG-
chimera-specific protein targets (Table S5). 60% of the IG-chi-
mera targets are shared with both IG-ARTD10 and IG-ARTD11
(Figure 4B). When the shared targets of ARTD10, ARTD11, and
the chimera are compared to the IG-chimera targets that are
only shared with ARTD10 (85% of the IG-chimera targets), it is
clear that the ARTD10cat domain plays an important role in target
selection (Figure 4B). However, it is also apparent that the loss of
the ARTD10 N terminus has drastically reduced the number of
proteins that can be targeted by the ARTD10cat domain. We
also noted that of the proteins identified in duplicate ARTD11
LC-MS/MS runs, only two were shared with the IG-chimera pro-
tein (NAGK andWRIP1, Tables S3 and S5). All of the nuclear pore
proteins require both the N terminus and the ARTD11cat domain
for MARylation. It is possible that the loss of ARTD11cat-depen-
dent enrichment to the nuclear membrane accounts for the loss
of nuclear pore protein targeting (Figure S4). Taken together,
these results suggest that both proximal and distal substrate in-
teractions are necessary for proper target selection and that the
structurally similar ARTDcat domains are playing distinct roles in
target selection.
To confirm all of our LC-MS/MS results with IG-ARTD10, IG-
ARTD11, and the IG-chimera protein, we selected ARTD10-spe-
cific (UBE3C and XPO5), ARTD11-specific (NXF1 and NUP98),
ARTD11-WWE-dependent (NAGK), and shared targets (WRIP1)
for identificationbywesternblotwith target specificantibodiesaf-
ter NeutrAvidin enrichment. For all of the IG constructs examined,
we observe robust enrichment of the auto-MARylated proteins
using the GFP antibody (Figures 4C and S3C). We only observe
enrichment of UBE3C and XPO5 in the ARTD10 lane and NXF1
and NUP98 in the ARTD11 lane (Figures 4C and S3C). This result
confirms that ourmethod is capableofdistinguishingbetween the
specific targets of multiple mono-ARTD family members from a
complexmixture. TheARTD11-specific target, NAGK, is enriched
in both the ARTD11 and chimera lane and is therefore dependent
primarily on ARTD11 N-terminal recognition for labeling (Figures
4C and S3C). Finally, the mono-ARTD pan-selective target,
WRIP1, is enriched in all three IG variant lanes (Figures 4C and
S3C). In each case, none of the selected targets are enrichedell Reports 14, 621–631, January 26, 2016 ª2016 The Authors 627
Figure 5. Validation of MARylation Targets
Identified via GFP-IG-ARTD-Modified 6-a-
NAD+ Pairs
(A) GFP-ARTD11 and HA-NXF1 are partially co-
localized at the nuclear membrane. HEK293T cells
co-expressing GFP-ARTD11 and HA-NXF1 were
fixed with paraformaldehyde and processed for
immunofluorescence. DNA was stained with
DAPI. Scale bar, 5 mm. Inset: white arrowheads
show co-localization.
(B) In vitro WT-ARTDcat MARylation assays
demonstrate that NXF1 is a preferred ARTD11
substrate. WT-ARTD10cat, -ARTD11cat, and
-ARTD7cat were screened for MARylation activity
using recombinant NXF1, SRPK2, and WRIP1 in
the presence of 6-a-NAD+. The same gel was
first fluorescently imaged to detect substrate
MARylation (top gel, gray) and then stained to
detect total substrate (bottom gel, blue).
(C) Quantification of results shown in (B). The bar
graphs below depict the MARylation activity for
each substrate with eachWT-ARTD (mean ± SEM,
n = 3). *p < 0.05 and **p < 0.01, two-tailed Stu-
dent’s t test. ns, not significant.
(D) Results from NXF1 in vitro MARylation assay
using full-length ARTD11 and 32P-NAD+. Full-
length ARTD11 or ARTD11CD was incubated with
NXF1 in the presence of 32P-NAD+ and ADPr
transfer was visualized using autoradiography
(left, gray) and stained to detect total substrate
(right, blue). Arrows indicate FL-ARTD11 and
NXF1.
See also Figures S4 and S5.from HEK293T lysates expressing theWT constructs, confirming
the necessity of the IGmutation for mono-ARTD family-member-
specific MARylation using 5-Bn-6-a-NAD+ (Figures 4C and S3C).
Our method is able to identify direct family-member-specific
mono-ARTD targets in complex lysates.
MARylation Targets of the Engineered ARTD-5-Bn-6-a-
NAD+ Pairs Are Bona Fide ARTD Substrates
We next sought to validate the direct targets of mono-ARTDs
identified using our chemical genetic strategy. We focused on628 Cell Reports 14, 621–631, January 26, 2016 ª2016 The Authorsthe putative ARTD11 target NXF1, an
mRNA binding protein that participates
in nucleocytoplasmic shuttling (Griffis
et al., 2003; Kang and Cullen, 1999). Us-
ing immunofluorescence, we found that
HA-NXF1 partially co-localized with
GFP-WT-ARTD11 at the nuclear mem-
brane in HEK293T cells (Figure 5A). This
result confirms that ARTD11 is found at
sites where NXF1 participates in nucleo-
cytoplasmic shuttling (Griffis et al., 2003;
Kang and Cullen, 1999). NXF1 was also
previously identified as a cellular ARTD
target in two separate studies exploring
the non-ARTD-specific PAR/MARylome
(Jungmichel et al., 2013; Zhang et al.,2013). Further, 54% of the specific ARTD10/11 targets identified
herein were previously identified as general ARTD targets in at
least one study (Table S6). Together, these data suggest that
our ARTD10/11-specific targets represent physiologically rele-
vant MARylation targets.
We next determined the in vitro selectivity of the WT-
ARTD10cat, ARTD11cat, and ARTD7cat enzymes for recombinant
substrates identified using our orthogonal pipeline. MARylation
of NXF1 was significantly higher in the presence of ARTD11 as
compared to ARTD10 and ARTD7 (Figures 5B and 5C). By
contrast, MARylation of SRPK2, a previously validated ARTD10
target (Haikarainen et al., 2013; Morgan and Cohen, 2015),
was significantly higher in the presence of ARTD10 as compared
to ARTD11 and ARTD7 (Figures 5B and 5C). Finally, WRIP1, the
dual ARTD10/ARTD11 target discussed above, was MARylated
to a similar degree by both ARTD11 and ARTD10 (Figures 5B and
5C). We confirmed that an active ARTD is required for selective
MARylation by incubating NXF1, SRPK2, and WRIP1 with the
IG/LG-ARTD variants in the presence of 6-a-NAD+. Without the
5-Bn-6-a-NAD+ analog, the IG/LG-ARTD variants will not trans-
fer ADP-ribose onto target proteins and act as non-enzymatic
MARylation controls. We did not observe any labeling with the
IG/LG-ARTD variants (Figure S5A). We also confirmed that
auto-MARylation of the individual ARTDcat domains was not
interfering with trans-MARylation; regardless of substrate, we
observed no appreciable auto-MARylation (Figure S5B). As
neither the IG-ARTD10 nor IG-Chimera label NXF1 at all in lysate,
these results confirm our previous observations that the N-termi-
nal domains play an important role in target discrimination. Yet,
clearly the ARTDcat domains retain some ability to differentiate
between mono-ARTD family-member-specific targets.
Finally, we wanted to confirm that NXF1 was a substrate
for full-length WT-ARTD11 (FL-ARTD11) using non-modified
32P-NAD+. While FL-ARTD11 undergoes auto-MARylation,
consistent with previous studies (Vyas et al., 2014), we found
that FL-ARTD11 preferentially MARylates NXF1 (Figure 5D).
MARylation of NXF1 was dependent on ARTD11 catalytic activ-
ity, as the catalytically inactive H197Amutant (FL-ARTD11CD) did
not modify NXF1 (Figure 5D). Together, these results show that
NXF1 is a bona fide target of ARTD11.
DISCUSSION
Our chemical genetic strategy to identify the direct targets of
mono-ARTDs works with multiple mono-ARTD family members
(ARTD10, 11, and 7). We discovered that the mutation that facil-
itated target identification with poly-ARTDs did not work for the
mono-ARTDs (L926 in the ceiling position in ARTD10). This could
be due to important differences in the manner in which the
ARTDs identify andmodify substrate targets. Further, the pocket
that we ultimately engineered was more efficient with a glycine
rather than an alanine at the key position (the I987G versus
I987A mutant). It is possible that the extra bulk of the alanine
side chain prevents binding of the benzyl adduct, or that the
glycine confers a greater deal of conformational flexibility to
the b strand near the NAD+-binding site. Future structural studies
with the various IG-ARTD variants and modified NAD+ analogs
could help discern how orthogonal NAD+ substrate switching
occurs in our IG-ARTD mutants. Nonetheless, our strategy pro-
vides a key approach for identifying the family-member-specific
targets for multiple mono-ARTDs.
The target lists generated from ARTD10 and ARTD11 revealed
how individual mono-ARTDs exhibit markedly different targeting
patterns in cellular lysate. While we focused on identifying the
protein targets for ARTD10 and ARTD11, we believe that our
strategy will be applicable for the identification of the direct
protein targets of the remaining mono-ARTD subclass. Com-
bined with our results identifying the targets of the poly-ARTDCsubclass, we have now established a clear path toward assign-
ing PARylated and MARylated protein targets to each individual
ARTD family member with a specific ADP-ribose transfer. More-
over, we have generated a database of ARTD10 and ARTD11
MARylation targets that can be used immediately to examine
the biological role of these mono-ARTDs in the cell.
The ARTD10 targets we identified share notable overlap with
previously reported cellular functions of ARTD10. In particular,
we noted the presence of a number of ubiquitin ligases (e.g.,
UBE3C) in our target dataset. ARTD10 contains two UIMs that
were shown to interact with ubiquitinylated tumor necrosis factor
receptor-associated factor (TRAF) to aid ARTD10 in targeting the
NF-kB essential modulator (NEMO) for MARylation (Verheugd
et al., 2013). An intriguing possibility is that ARTD10 regulates
the ubiquitin signal cascade through MARylation of ubiquitin li-
gases. Additionally, ARTD10 has been implicated in the coordi-
nation of cellular trafficking (Kleine et al., 2012), and we indeed
find a number of cellular trafficking proteins in our target dataset
(Tables S1 and S2).
However, while the target list for ARTD10 most likely contains
a number of targets that are involved in specific signaling events
mediated by ARTD10, we were still surprised by the broad array
of cellular targets that are MARylated by ARTD10 and have no
clear functional relationship to each other. We propose that the
broad promiscuity evidenced by ARTD10 might actually play a
role in the function of ARTD10 in the cell. ARTD10 has been
shown to interact with p62, a ubiquitin receptor associated
with autophagy (Kleine et al., 2012). In certain conditions,
ARTD10 forms cytosolic clusters that bind p62, which implicates
ARTD10 in trafficking targets to the autophagosome. It is there-
fore possible that, in this role, ARTD10 is modifying a broad array
of targets that are being sent to the autophagosome for degrada-
tion. Further exploration of the role for ARTD10 in autophagy will
be required to determine if the broad targeting of ARTD10 is
important for its function in this pathway.
Compared to ARTD10, relatively little is known regarding the
function of ARTD11 in the cell. Recent work has linked
ARTD11 to nuclear shaping in spermatids undergoing nuclear
condensation and differentiation (Meyer-Ficca et al., 2015), yet
the ARTD11-specific targets responsible for this process are un-
known. The ARTD11 targets we identified appear to be directly
related to the coordination of the nuclear envelope and the orga-
nization of nuclear pores (Table S3). One of the ARTD11-specific
targets we identified, the nuclear pore complex protein Nup98-
Nup96 (NUP98), was previously found to interact with ARTD11
(http://thebiogrid.org/). Our target list for ARTD11 provides a
clear point of entry for exploring in molecular detail how
ARTD11 MARylation regulates nuclear pore complex biology.
One of the remaining challenges in understanding the relation-
ship between ARTD family-member-specific targeting and
cellular function is the identification of the specific amino
acids targeted by a given mono-ARTD. It appears that, while
PARylation primarily targets acidic amino acids (i.e., glutamate
and aspartate), MARylation may be more promiscuous in its
site selection. Indeed, a recent study demonstrated that mono-
ARTDs could be auto-MARylated not only on glutamate and
aspartate, but also on lysine and cysteine (Vyas et al., 2014).
The identity of the MARylated amino acids will be essential forell Reports 14, 621–631, January 26, 2016 ª2016 The Authors 629
more complete understating of mono-ARTDs functions in cells.
We envision that the method described here could be coupled
with a recently described method to globally identify PARylated
andMARylated sites in protein targets (Daniels et al., 2014). Opti-
mally, we would like to expand our method to include membrane
permeant versions of the NAD+ analogs to identify the changes in
mono-ARTD targeting at specific cellular locations during
various stimuli. Combined with current replacement strategies
for swapping the genomic version of a given mono-ARTD with
our sensitized allele (e.g., CRISPR-Cas systems), we can use
our strategy to connect ARTD targeting to a specific site on a
protein substrate and delve deeper into the functional role of
MARylation in the cell.
EXPERIMENTAL PROCEDURES
Cell Culture and Immunofluoresence
HEK293T and HeLa cells were grown in DMEM (Gibco) supplemented with
10% fetal bovine serum (FBS, HyClone), penicillin/streptomycin (Invitrogen),
and 1 3 glutamax (Gibco) at 37C and 5% CO2. Transient transfections of
HEK293T cells with 20 mg of GFP-tagged expression vectors per 10-cm dish
(70% confluency) were performed using the CalPhos system (Clontech) ac-
cording to manufacturer’s instructions. Transient transfections of HeLa cells
were performed with 15 mg GFP-tagged expression vectors and 30 mg lipofec-
tion reagent per 10-cm dish using Lipofectamine 2000 (Invitrogen). Cells were
lysed in HEPES buffer supplemented with cOmplete EDTA-free protease in-
hibitor (Roche), and cell debris was cleared by centrifugation at 14,000 3 g
for 5 min at 4C. Immunofluoresence localization experiments with GFP-
ARTD11 and HA-NXF1 were performed as previously described (Griffis
et al., 2002). Images were collected on an ApoTome microscope (Zeiss) and
were processed using ImageJ. z stacks were compressed as maximal 2D pro-
jections and background subtraction was completed using the Rolling Ball
Background Subtraction plugin (radius = 8).
Chemical Synthesis
Synthesis of 6-a-NAD+ and 5-Et-6-a-NAD+ was completed as previously
described (Carter-O’Connell et al., 2014). See the Supplemental Experimental
Procedures for details regarding the synthesis of the remainingC-5 substituted
NAD+ analogs (Scheme S1).
SRPK2 MARylation Assay
1 mM of each ARTD10cat variant was incubated with 3 mM SRPK2 and 100 mM
of each modified NAD+ analog for 2 hr at 30C in a 20 ml reaction volume con-
sisting of 50 mM HEPES (pH 7.5), 100 mM NaCl, 10 mM MgCl2, and 0.5 mM
TCEP. Click conjugation was performed with 1.5 mM THPTA, 750 mM
CuSO4, 300 mMsulforhodamine B-PEG3-azide, and 7.5mM sodium ascorbate
in 13 PBS for 1 hr at room temperature. SRPK2 labeling was quantified using
Image Lab v5.2 (Bio-Rad).
ARTDcat Selectivity Assay
250 nM of WT-ARTD10cat, -ARTD11cat, or -ARTD7cat was incubated with 3 mM
of SRPK2, NXF1, or WRIP1 and 100 mM of 6-a-NAD+ for 2 hr at 30C in a 12 ml
reaction volume consisting of 50 mM HEPES (pH 7.5), 100 mM NaCl, 15 mM
MgCl2, and 0.5 mM TCEP. Click conjugation was performed with 100 mM
TBTA, 1 mM CuSO4, 100 mM sulforhodamine B-PEG3-azide, 1% SDS, and
1 mM sodium ascorbate in 13 PBS for 30min at room temperature. Substrate
labeling was quantified using Image Lab v5.2 (Bio-Rad) and normalized
against the total substrate load as determined using SafeStain (Thermo Fisher
Scientific). The ARTD activity was normalized for each individual substrate.
FL-ARTD11 Activity Assay
Reactions containing either 0.2 mM NXF1, 0.2 mM FL-ARTD11 (recombinantly
expressed and purified from E. coli), or both were performed in assay buffer
(50 mM Tris-HCL [pH 7.5], 50 mMNaCl, 2 mMMgCl2) at room temperature us-630 Cell Reports 14, 621–631, January 26, 2016 ª2016 The Authorsing a mixture of cold NAD+ (5 mM) and [32P]-NAD+ (2 mCi per reaction). After
30-min reactions were stopped by adding SDS-PAGE loading buffer and
boiled at 80C for 5 min. All reactions were resolved on 4%–12% SDS–
PAGE gels. ADP-ribosylated proteins were visualized by autoradiography.
NeutrAvidin Enrichment and LC-MS/MS Analysis
1mg of total protein from either HEK293T or HeLa lysate from cells expressing
WT- or IG-tagged ARTD variants was incubated with 100 mM 5-Bn-6-a-NAD+
for 2 hr at 30C, click conjugated to biotin-PEG3-azide, and subjected to
enrichment using NeutrAvidin agarose (Pierce) and proteolysis as previously
described (Carter-O’Connell and Cohen, 2015; Carter-O’Connell et al.,
2014). MS experiments were performed using an Orbitrap Fusion (Thermo)
equipped with a capillary HPLC system. MS processing and analysis thresh-
olds are discussed in Supplemental Experimental Procedures.
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